Source:http://linkedlifedata.com/resource/lhgdn/association:125
| Subject | Predicate | Object | Context |
|---|---|---|---|
| lhgdn:association:125 | lhgdn:found_in | pubmed-article:18709641 | lld:lhgdn |
| lhgdn:association:125 | lhgdn:geneRifSource | the 4 biomarkers CLU, ITGB3, PRAME and CAPG may be used as prognostic factors for patients with stage III serous ovarian adenocarcinomas. | lld:lhgdn |
| lhgdn:association:125 | lhgdn:mesh_code | D000230 | lld:lhgdn |
| lhgdn:association:125 | lhgdn:associationIdType | http://bio2rdf.org/euadr:Po... | lld:lhgdn |
| lhgdn:association:125 | lhgdn:umls_code | umls-concept:C0205641 | lld:mappings |
| entrez-gene:3690 | lhgdn:associationId | lhgdn:association:125 | lld:lhgdn |